Ekso Bionics (EKSO) Reports In-Line Q2 EPS

Ekso Bionics (NASDAQ: EKSO) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $5 million versus the consensus estimate of $5.15 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• Arxis, Inc. (ARXS) Reports Q2 EPS of $0.28; offers guidance
• Silicon Motion Technology (SIMO) Tops Q2 EPS by 32c
• NorthWestern (NWE) Misses Q2 EPS by 3c; offers guidance